4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pulse Biosciences, Inc. (PLSE) operates in the Medical Instruments & Supplies industry and is headquartered in Miami, United States with about 116 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, PLSE reported $0M in revenue and ($73M) in net income.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Interactive charts & full statements → Open the PLSE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | — |
| Gross Profit | ($0M) | $0M | $0M | ($11M) | — |
| Operating Income (EBIT) | ($77M) | ($56M) | ($44M) | ($58M) | — |
| Net Income | ($73M) | ($54M) | ($42M) | ($58M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | ($0M) | — | $0M | — |
| Operating Income (EBIT) | ($19M) | ($18M) | ($20M) | ($20M) | ($18M) | — |
| Net Income | ($19M) | ($17M) | ($19M) | ($19M) | ($17M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $94M | $132M | $59M | $78M | — |
| Total Liabilities | $14M | $18M | $15M | $80M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PLSE viewer.
About TickerBase · Data methodology & sources